Work

A Phase 1 first-in-human study of MEDI0680, an anti-PD-1 monoclonal antibody (mAb) in adult patients (pts) with advanced tumors

Year: 2016

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw378.26

Authors: A. Naing, S. Goel, B. Curti, A. Weise, J.P. Eder, S. Marshall, C. Morehouse, X. Li, J.J. Karakunnel, J. Infante

Institutions: The University of Texas MD Anderson Cancer Center, The Barbara Ann Karmanos Cancer Institute, Yale Cancer Center, Sarah Cannon, Tennessee Oncology

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2587486446

FWCI:

Cites:

Cited by: 1

Related to: 10